Influence of Sleep Regularity on Circadian Rhythms, Learning, Performance, and Mood
1 other identifier
interventional
27
1 country
1
Brief Summary
The study is a combination of outpatient and inpatient monitoring. During the 27-day inpatient portion of the study, the individual's sleep-wake schedule will be varied daily. Volunteers will be randomized to a regular or irregular inpatient schedule.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2016
CompletedFirst Posted
Study publicly available on registry
July 20, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 20, 2026
January 1, 2026
4.4 years
July 15, 2016
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Circadian phase
Circadian phase, as measured by melatonin, at end vs. beginning of inpatient portion of experiment
27 days
Learning
Sleep-dependent learning at 3-4 times during inpatient portion of the experiment
27 days
Mood
Mood (using a linear non-numeric scale) across difference days inpatient portion of the experiment
27 days
Study Arms (2)
Regular Schedule
EXPERIMENTALParticipant will be on a regular sleep/wake schedule
Irregular Schedule
EXPERIMENTALParticipant will be on an irregular sleep/wake schedule
Interventions
Eligibility Criteria
You may qualify if:
- healthy
- BMI between 18.5 and 29.5
You may not qualify if:
- medications
- recent night-work, shift-work, or travel across \>2 time zones
- use of medications
- pregnant or within 6 months post-partum
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth B Klerman, MD PhD
Brigham and Women's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 15, 2016
First Posted
July 20, 2016
Study Start
November 1, 2016
Primary Completion
April 1, 2021
Study Completion
December 1, 2025
Last Updated
January 20, 2026
Record last verified: 2026-01